Nephro Care India Ltd
NEPHROCARENephro Care India Ltd
NEPHROCARE
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 21.61 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.92 | 6.65 | 0.51% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Nephro Care India is an India-based healthcare provider that specializes in the treatment of kidney-related diseases.
Peers
Compare with peersMax Healthcare Institute Ltd
Apollo Hospitals Enterprise Ltd
Fortis Healthcare Ltd
Global Health Ltd
Narayana Hrudayalaya Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.55 | 1.83 | 3.42 | 18.21 | 27.96 | — | ||||||
Raw Materials | 0.00 | 1.25 | 1.63 | 5.28 | 8.95 | — | ||||||
| Power & Fuel Cost | 0.06 | 0.06 | 0.03 | 0.15 | 0.26 | |||||||
| Employee Cost | 0.15 | 0.15 | 0.31 | 1.11 | 2.16 | |||||||
| Selling & Administrative Expenses | 0.01 | 0.18 | 1.17 | 8.03 | 9.05 | |||||||
| Operating & Other expenses | 0.31 | 0.03 | 0.16 | 0.22 | 0.79 | |||||||
EBITDA | 0.02 | 0.16 | 0.12 | 3.42 | 6.75 | — | ||||||
| Depreciation/Amortization | 0.00 | 0.01 | 0.11 | 0.78 | 0.53 | — | ||||||
| PBIT | 0.02 | 0.15 | 0.01 | 2.64 | 6.22 | — | ||||||
| Interest & Other Items | 0.04 | 0.03 | 0.02 | 0.07 | 0.09 | — | ||||||
| PBT | -0.02 | 0.12 | -0.01 | 2.57 | 6.13 | — | ||||||
| Taxes & Other Items | 0.00 | 0.03 | 0.01 | 0.20 | 1.72 | — | ||||||
| Net Income | -0.02 | 0.09 | -0.02 | 2.37 | 4.41 | — | ||||||
| EPS | -1.00 | 4.50 | -0.04 | 2.37 | 4.03 | — | ||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Nephro Care India Ltd | 73.59 | 21.61 | — |
| Max Healthcare Institute Ltd | 109.68 | 13.80 | 0.13% |
| Apollo Hospitals Enterprise Ltd | 115.81 | 14.22 | 0.22% |
| Fortis Healthcare Ltd | 86.06 | 6.02 | 0.15% |
Price Comparison
Compare NEPHROCARE with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 12.52%
Increased Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has increased by 3.92%
Shareholding Pattern
Apr 2024
Jun 2024
Jul 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
NEPHROCARE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNephro Care India will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live
Nephro Care India announced that the 10th Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live
Nephro Care India will hold a meeting of the Board of Directors of the Company on 20 August 2024.Powered by Capital Market - Live
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 23.64%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant